Eyenovia, Inc. (NASDAQ:EYEN) Sees Large Increase in Short Interest

Eyenovia, Inc. (NASDAQ:EYEN) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 4,590,000 shares, an increase of 17.7% from the December 15th total of 3,900,000 shares. Based on an average daily trading volume, of 20,560,000 shares, the short-interest ratio is currently 0.2 days.

Institutional Trading of Eyenovia

Large investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its stake in Eyenovia by 36.6% during the 3rd quarter. Geode Capital Management LLC now owns 557,994 shares of the company’s stock worth $288,000 after purchasing an additional 149,471 shares in the last quarter. Armistice Capital LLC bought a new stake in Eyenovia during the 2nd quarter worth approximately $3,601,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in Eyenovia during the 2nd quarter worth approximately $26,000. SkyView Investment Advisors LLC bought a new stake in Eyenovia during the 2nd quarter worth approximately $87,000. Finally, Financial Management Network Inc. bought a new position in shares of Eyenovia during the 3rd quarter worth approximately $39,000. 25.84% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. LADENBURG THALM/SH SH restated a “neutral” rating on shares of Eyenovia in a research report on Monday, November 18th. HC Wainwright downgraded shares of Eyenovia from a “buy” rating to a “neutral” rating and cut their target price for the company from $12.00 to $2.00 in a research report on Monday, November 18th. Brookline Capital Management reiterated a “hold” rating on shares of Eyenovia in a research report on Friday, November 15th. Finally, William Blair reiterated a “market perform” rating on shares of Eyenovia in a research report on Friday, November 15th.

Eyenovia Trading Down 5.2 %

Shares of NASDAQ:EYEN traded down $0.00 during mid-day trading on Friday, reaching $0.06. The stock had a trading volume of 34,207,602 shares, compared to its average volume of 44,044,192. The firm has a market cap of $6.98 million, a PE ratio of -0.09 and a beta of 1.31. The firm has a 50 day simple moving average of $0.13 and a two-hundred day simple moving average of $0.50. The company has a current ratio of 0.74, a quick ratio of 0.55 and a debt-to-equity ratio of 0.58. Eyenovia has a twelve month low of $0.06 and a twelve month high of $2.57.

Eyenovia (NASDAQ:EYEN) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.02. Eyenovia had a negative net margin of 114,639.41% and a negative return on equity of 1,108.24%. During the same period in the prior year, the business posted ($0.18) EPS. On average, research analysts predict that Eyenovia will post -0.5 EPS for the current fiscal year.

Eyenovia Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.